Bibliographic Details
| Title: |
Chemogenomic analysis identifies Macbecin II as a compound specific for SMAD4-negative colon cancer cells. |
| Authors: |
Kaiser C; Pharmaceutical Genomics Division, The Translational Genomics Research Institute, Scottsdale, AZ 85259, USA., Meurice N, Gonzales IM, Arora S, Beaudry C, Bisanz KM, Robeson AC, Petit J, Azorsa DO |
| Source: |
Chemical biology & drug design [Chem Biol Drug Des] 2010 Apr; Vol. 75 (4), pp. 360-8. |
| Publication Type: |
Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: |
Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101262549 Publication Model: Print Cited Medium: Internet ISSN: 1747-0285 (Electronic) Linking ISSN: 17470277 NLM ISO Abbreviation: Chem Biol Drug Des Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
